Patents by Inventor Doan-Ngoc DUC

Doan-Ngoc DUC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11973808
    Abstract: An electronic device is provided. The electronic device includes a communication circuit, a memory, and a processor configured to identify an occurrence of a conference event for establishing a conference call in which a plurality of external electronic devices participate, identify whether at least one of the plurality of external electronic devices is anonymous, generate an identification key to be mutually shared by a pair of an anonymous electronic device among the plurality of external electronic devices and the electronic device and transmit the identification key to the anonymous electronic device through the communication circuit when the at least one of the plurality of external electronic devices is anonymous, and generate the conference call in which the plurality of external electronic devices participate.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: April 30, 2024
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Nguyen Ngoc Duc, Nguyen The Nghia, Tran Xuan Toan, Doan Huy My, Nguyen Van Hien, Nguyen Van Sinh, Pham The Huy
  • Publication number: 20210322509
    Abstract: A method for preventing or reducing the risk of perinatal or neonatal morbidity and mortality caused by antenatal inflammation in humans is described. This method is based on the administration of a compound of formula I or a pharmaceutically acceptable salt thereof: to an expectant human mother suffering from antenatal fetal inflammation. The method prevents or reduces the risk of organ damages, including brain, lung and intestinal damages, and sequelae therefrom, in the neonates, as well as the risk of neonatal death.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 21, 2021
    Applicants: CHU SAINTE-JUSTINE, UNIVERSITÉ DE MONTRÉAL, THE UNIVERSITY OF ADELAIDE
    Inventors: Sylvain CHEMTOB, Christiane QUINIOU, Sarah Anne ROBERTSON, Mathieu NADEAU-VALLÉE, William D. LUBELL, David OLSON, Peck Yin CHIN, Sylvie GIRARD, Doan-Ngoc DUC
  • Publication number: 20190091279
    Abstract: A method for preventing or reducing the risk of perinatal or neonatal morbidity and mortality caused by antenatal inflammation in humans is described. This method is based on the administration of a compound of formula I or a pharmaceutically acceptable salt thereof to an expectant human mother suffering from antenatal fetal inflammation. The method prevents or reduces the risk of organ damages, including brain, lung and intestinal damages, and sequelae therefrom, in the neonates, as well as the risk of neonatal death.
    Type: Application
    Filed: March 9, 2016
    Publication date: March 28, 2019
    Inventors: Sylvain CHEMTOB, Christiane QUINIOU, Sarah Anne ROBERTSON, Mathieu NADEAU-VALLÉE, William D. LUBELL, David OLSON, Peck Yin CHIN, Sylvie GIRARD, Doan-Ngoc DUC